Bill

Bill > SB1654


TN SB1654

TN SB1654
AN ACT to amend Tennessee Code Annotated, Title 8, Chapter 4; Title 9; Title 47, Chapter 18; Title 56 and Title 63, relative to funding oversight.


summary

Introduced
01/14/2026
In Committee
Crossed Over
03/26/2026
Passed
04/23/2026
Dead
Signed/Enacted/Adopted
04/27/2026

Introduced Session

114th General Assembly

Bill Summary

As enacted, clarifies that, as of November 1, 2026, a non-governmental entity receiving in-kind funding from the state or a political subdivision of the state pursuant to the federal Public Health Service Act is eligible to qualify as a 340B entity, only if the entity is also a recipient of one or more state or federal grant awards that are subject to audit, reporting, and oversight requirements under state and federal law; authorizes the comptroller of the treasury and any state agency or political subdivision providing in-kind funding to verify eligibility and enforce compliance. - Amends TCA Title 8, Chapter 4; Title 9; Title 47, Chapter 18; Title 56 and Title 63.

AI Summary

This bill, effective November 1, 2026, amends Tennessee law to establish new requirements for non-governmental entities receiving in-kind funding from the state or local governments, specifically when that funding is related to certain public health services (as defined by sections 317 and 318 of the Public Health Service Act, which are federal laws). To be considered a "340B entity," which is a designation related to drug pricing programs, these entities must also receive state or federal grant awards that are subject to regular audits and reporting. The Comptroller of the Treasury, along with any state agency or local government providing this in-kind funding, will have the authority to check if these entities meet these new eligibility criteria and to ensure they are following the rules.

Committee Categories

Government Affairs

Sponsors (2)

Last Action

Effective date(s) 11/01/2026 (on 04/27/2026)

Bill Topics

Government Operations
  • ‐ Government Efficiency and Bureaucratic Oversight
Health
  • ‐ Regulation of Drug Industry and Pharmacies

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...